Register before March 2nd & Save €300
SAS is the global market leader in analytics with sales of $3.2 billion. The solutions help companies at more than 83,000 locations around the world to use their diverse business data to obtain concrete information for strategic decisions and thus improve their performance.
With SAS companies develop products, implement strategies, measure their own success, shape their customer and supplier relationships profitably, optimize their production in real time and fulfil regulatory requirements.
Founded in 1976 and with its headquarter in Cary, North Carolina. SAS DACH headquarter is located in Heidelberg with offices in Berlin, Cologne, Frankfurt, Hamburg, Munich, Vienna and Zurich.
For further information, please visit www.sas.com.
For over a decade, organizations around the world have come to rely on MarkLogic to power their innovative information applications. As the world’s experts at integrating data from silos, MarkLogic’s operational and transactional Enterprise NoSQL database platform empowers our customers to build modern applications on a unified, 360-degree view of their data. Headquartered in Silicon Valley, MarkLogic has offices throughout the U.S., Europe, Asia, and Australia.
IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 55,000 employees worldwide. Learn more at iqvia.com.
More information coming soon...
Caligor partners with pharmaceutical and biotechnology companies to provide consultation on global medicine access strategies as well as leads the program implementation and daily management of global access requests including delivery of drug to site. These programs, known as Expanded Access, Compassionate Use or Early Access, provide physicians and patients with investigational / unlicensed medicines where there is critical need outside of the clinical or commercial environment. Caligor's leadership team leverages deep experience and insight to help companies "bridge the gap" between medicines with limited availability and their patients in need.
For more information, please contact Karen Frascello, Vice President, Business Development at email@example.com
Download the detailed event brochure here
eyeforpharma is a registered company in England and Wales - Registered number 09823909. 7-9 Fashion Street, London, E1 6PX, UK. Contact Us.
Website Development by Fruitbowl Media Ltd.